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Abstract
Background: Maintaining a bio-ontology in the long term requires improving and updating its contents so that it
adequately captures what is known about biological phenomena. This paper illustrates how these processes are
carried out, by studying the ways in which curators at the Gene Ontology have hitherto incorporated new
knowledge into their resource.
Results: Five types of circumstances are singled out as warranting changes in the ontology: (1) the emergence of
anomalies within GO; (2) the extension of the scope of GO; (3) divergence in how terminology is used across user
communities; (4) new discoveries that change the meaning of the terms used and their relations to each other;
and (5) the extension of the range of relations used to link entities or processes described by GO terms.
Conclusion: This study illustrates the difficulties involved in applying general standards to the development of a
specific ontology. Ontology curation aims to produce a faithful representation of knowledge domains as they keep
developing, which requires the translation of general guidelines into specific representations of reality and an
understanding of how scientific knowledge is produced and constantly updated. In this context, it is important
that trained curators with technical expertise in the scientific field(s) in question are involved in supervising
ontology shifts and identifying inaccuracies.
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Background
The Importance of Shifting Ontology
The Gene Ontology [GO] provides a representation of
biological knowledge through the use of precisely
defined, interrelated terms [1,2]. For GO to successfully
underpin data-driven discovery and database searches,
the definitions of the terms used, and their relations to
each other, need to accurately portray existing biological
knowledge about entities and processes. Thus, a key
challenge for the long-term maintenance of GO consists
of updating its contents to reflect new scientific devel-
opments that challenge established biological knowledge
[3]. GO curators have been aware of this since the crea-
tion of GO [4] and have sought to establish mechanisms
of feedback, so that users of GO could alert curators to
any discrepancy between the understanding of given
entities or processes routinely used within their own
fields and the representation of that knowledge provided
in the ontology [5]. Indeed, the capability of bio-
ontologies such as GO to reflect new developments as
they arise has been highlighted as key to their increasing
popularity [6,7].
GO was created in 1999 and is thus one of the long-
est-running ontologies within the Open Biomedical
Ontologies (OBO). This paper explores how, in the
course of its existence, GO has evolved to represent bio-
logical knowledge. We review the changes that have
been applied to how GO terms are defined and related
to each other, with a view to clarifying whether and
how the content of GO has been modified to adequately
fit new evidence. Reviewing how GO has been devel-
oped over the years is an important way for the users of
GO and biologists in general to understand the pro-
cesses involved in ontology development. This paper
aims to provide biologists who are not normally
involved in the development of ontologies with an
understanding of the amount of conceptual and practi-
cal effort needed in this area, as well as the expertise
involved. We therefore do not focus on changes imple-
mented to improve the interoperability and internal
coherence of GO, e.g. [8]; nor do we discuss how con-
formance to OBO rules or Basic Formal Ontology
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has been dealt with elsewhere [6]. Our study focuses on
cases of ontology shifts that occurred in order to
improve the ways in which GO represents biological
knowledge. Ontology shifts are defined as changes to
the biological content of GO, including changes in the
definitions of GO terms, the order in which GO terms
are situated in the network hierarchy, the relations used
to link these terms and the links made between terms
and data and/or meta-data.
Results
Ontology shift 1: Dealing with anomalies
One type of ontology shift occurs when curators become
aware of a mismatch between GO representation and
reality, leading to a term being incorrectly related to
other terms in the ontology. The discovery of such
anomalies leads to revisions of the ontology, which
needs to be both internally consistent and faithfully
representing reality.
As an example, consider the GO process term “sero-
tonin secretion”. Serotonin is a small molecule pro-
duced by a variety of cells, including neurons,
enterochromaffin cells, basophils, and mast cells. It
plays several roles in the body, most famously as a neu-
rotransmitter, but also in contraction of the gut and
mediation of allergic inflammation by mast cells. The
term “serotonin secretion” was initially added to the
ontology as an is_a descendant of both “hormone secre-
tion” and “neurotransmitter secretion,” since the neuro-
transmitter and hormone roles of this molecule were
the only roles considered when the term was developed.
When a new term “serotonin secretion during acute
inflammatory response” was subsequently created as an
is_a descendant of “serotonin secretion” (Figure 1A) it
was realised that it was not biologically accurate to state
that “serotonin secretion during acute inflammatory
response” was a subtype of “neurotransmitter secretion,”
because in inflammatory responses serotonin acts on
target cells other than neurons. The erroneous place-
ment of “serotonin secretion” was corrected resulting in
the graph shown in Figure 1B. The new term “serotonin
secretion, neurotransmission” was added as a subclass
of “serotonin secretion” to capture the process of sero-
tonin secretion during neurotransmission.
Another example is the disambiguation of immune
responses from defense responses. Regulatory immune
responses such as those involved in tolerance induction
to non-self antigens, which prevent inappropriate
responses to substances in food, for instance, challenge
the idea that every “immune response” is also a “defense
response”. Yet, these two terms were initially repre-
sented as synonymous within GO. This situation was
discussed during a GO meeting at The Institute for
Genomic Research in November 2005. Several biological
cases were presented as anomalous under the current
description, and it was determined that this warranted a
broad shift in the ontology itself. “Immune response”
and “defense response” thus became terms that share a
common ancestor term but have no direct relationship
between them. This enabled curators to distinguish
between the two types of responses, while signalling
their common origin as a reaction to a stimulus.
Ontology shift 2: Expanding scope
A second type of ontology shift occurs when GO needs
to be extended to cover terminology and data coming
from new research fields, biological issues or species.
The problems caused by the addition of immunologi-
cal terms illustrate what happens when including knowl-
edge from a new field into the ontology. The scope of
what GO considered an “immune response” was
expanded by a major revision discussed at a GO meet-
ing in 2005 [9] and completed in September 2006 [10],
as still it became clear that the concept of having an
“immune system” was not restricted to vertebrates. Biol-
ogists working in both invertebrate and plant systems
used the term “immune system” to describe the cells
and biological processes mediating innate immune
responses in these organisms [11]. Until the revision,
GO had considered immune responses in higher verte-
brates only, and terms related to innate immune
responses in other organisms, such as the “incompatible
interaction” of plants and “melanization defense
response” in insects, were found in other areas of GO.
After the revision, all the various types of immune
responses in different organisms were grouped together
as types of “immune response”.
What happens when GO is expanded to cover a new
biological issue is illustrated by the 2004 development of
ontology to describe host-parasite interactions. The early
versions of GO contained few terms to describe the inter-
actions that occurred between hosts and their symbionts.
Those that did exist, such as “evasion of host defense
response” and “cell invasion,” shared no common ances-
tor and were often ill-defined with respect to which
organism in a particular interaction the term was refer-
ring to. For example, the process of cell lysis can be
induced in a host organism by its parasite, or can be an
endogenous process whereby the immune system
destroys its own infected cell, but both were represented
by a single term, “cytolysis”. In 2004 the PAMGO (Plant-
Associated Microbe Gene Ontology, http://pamgo.vbi.vt.
edu) Consortium was formed and worked with GO to
develop terms relating to host-parasite interactions, spe-
cifically for plant parasites. The initial set of around 450
terms added to biological process had a single ancestor
term “interaction between organisms” (later to be
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encompassed host-parasite interactions but also pro-
cesses as diverse as “female pregnancy” and “biofilm for-
mation”. The multi-organism process sub-hierarchy now
contains over 1300 terms, and in addition there are
around 80 terms in cellular component to describe loca-
tions within other organisms, such as “host”.T h ei n t r o -
duction of these terms also required a change to the
annotation methodology such that information about the
taxon of both the species involved in an interaction could
be captured (see http://www.geneontology.org/GO.anno-
tation.conventions.shtml#interactions).
Finally, ontology shifts have frequently occurred when
GO was expanded to include data from a new species.
GO aims to support the comparative analysis of gene
products across species, and its terms need to accom-
modate differences in the biology of organisms ranging
from fruitflies to mice and plants [12]. Especially when
grouping together species coming from different king-
doms, GO has been radically modified to avert the dan-
ger of biological inaccuracies. When GO was first
applied to prokaryotic gene products, for instance, many
relationships within the cellular component ontology,




Figure 1 A shows the initial anomalous placement of the term “serotonin secretion,” and B shows its corrected position in the current
GO biological process ontology hierarchy.
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have nuclei or several other membrane-bounded orga-
nelles. For example, the enzyme complexes that carry
out the reactions of the TCA cycle (also known as the
Krebs cycle or citric acid cycle) are located in the mito-
chondrial matrix in eukaryotes. Cellular component
terms representing these complexes were originally
grouped under ‘tricarboxylic acid cycle enzyme com-
plex’, which was in turn part_of “mitochondrial matrix”.
In bacteria, which do not have mitochondria, analogous
complexes are located in the cytosol; the way in which
GO related the TCA cycle complex terms to “mitochon-
drial matrix” was thus inaccurate (Figure 2a). To address
this, the existing term was renamed to add “mitochon-
drial”, thus making information that was implicit in the
ontology structure explicit in term names. Two new
terms were then added, one of which uses the non-loca-
tion-specific name, and is a descendant of “cytoplasm";
the second new term has a name and path specifying
that the complex is located in the cytosol (Figure 2b).
Ontology shift 3: Dealing with diverging definitions
across communities
A third type of ontology shift results from the need to
deal with diverging definitions across research commu-
nities. Often, given the diversity and fragmentation typi-
cal of biological and biomedical research, the same
phrase is used in different ways depending on the
research context [3]. Maintaining univocity (a word or
phrase having a single meaning) is essential in develop-
ing unambiguous ontologies, so it is necessary to alter
the structure of GO where cases of multiple meaning
for a word or phrase arise. Not surprisingly, this type of
ontology shift often coincides with ontology shifts of
type three detailed above: divergence in the use of terms
across communities are commonly discovered when
new terminologies, fields or species are added to GO.
The 2001 transition to include plants in the ontology is
a case in point. Early on, GO had only one term for
gamete formation: “gametogenesis”, which was defined as
the “generation, maintenance, and proliferation of
gametes”.T h em e a n i n go f“gamete” was not specified,
but the term and definition were generated with animal
gamete formation in mind. Plant biologists, however, use
“gametogenesis” to refer to the generation of a gameto-
phyte, that is, a plant in the haploid phase that can pro-
duce gametes. An extensive set of changes was required
to remove ambiguity in the usage of “gametogenesis”,
and add terms to represent plant biology. The definition
of “gametogenesis” was altered to define gamete as “a
haploid reproductive cell” and to remove the mention of
proliferation. For plant processes, a new term “gameto-
phyte development” was added, its name and definition
clearly referring to the relevant phase of a plant life cycle.
Ontology Shift 4: Mirroring scientific advance
A fourth type of ontology shift occurs in response to
new evidence which changes the understanding of a
given entity or process so that its definition and rela-
tions to other terms also need to change.
A ne x a m p l eo ft h i si n v o l v e st h et e r m“cytoskeleton”.
For several decades, cytoskeletal structures such as
microfilaments, microtubules, and intermediate fila-
m e n t sw e r eo b s e r v e do n l yi ne u k a r y o t i cc e l l s ,a n dw e r e
therefore thought to be absent from prokaryotic cells.
Accordingly, the definition for the GO cellular compo-
nent term “cytoskeleton” followed one of many diction-
ary and textbook definitions, beginning “Any of the
various filamentous elements that form the internal fra-
mework of eukaryotic cells”. In recent years, however,
evidence has accumulated that bacterial cells do contain
cytoskeletal structures [13,14]. To accommodate these
discoveries, and to facilitate annotation of bacterial
cytoskeletal gene products the GO definition had to be
broadened to remove the word “eukaryotic”,a n dw i t hi t
the restriction on species to which the term could be
applied. Deletion of a single word from a term definition
thus allowed GO to capture a revolutionary advance in
the research community’s understanding of both prokar-
yotic cell organization and the taxonomic distribution of
cytoskeletal structures.
The definition of the term “conoid” is another exam-
ple of how ontology can shift in response to scientific
developments. The conoid is a cytoskeletal element that
forms part of the apical complex, a distinctive and ela-
borate structure found in apicomplexan parasites [15].
Based on electron microscopic analysis, the conoid was
known to consist of fibers; based on the prevailing
hypothesis that the fibers were microtubules, GO
included a cellular component term, “conoid”,w h i c h
was an is_a descendant of “microtubule”. The definition
was: “Coiled microtubules within both the polar and
basal rings of the apical complex of an apicomplexan
parasite.” More recently, Hu et al. [16] showed that the
conoid is indeed composed primarily of tubulin, but the
tubulin structure differs markedly from that of typical
microtubules. This improved understanding of conoid
structure had two consequences for “conoid”.F i r s t ,t h e
is_a relationship to “microtubule” was removed, because
the conoid could no longer be considered a type of
microtubule. Second, the text definition was changed to
remove information now known to be false and to more
accurately describe the structure of a conoid.
Ontology shift 5: Adding relations
One last type of ontology shift concerns changes to the
type of relations deemed to hold between ontology
terms. This shift is more complex than the previous
four, since it potentially affects the whole ontology and
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implemented.
As originally used in GO, the part_of relationship was
not rigorously defined. This led to a number of
problems, one of the biggest ones being that the part_of
relationship in GO was being used with different levels
of stringency: in some cases all of the subclass is part of








































Figure 2 A shows the initial anomalous parentage of the term “’tricarboxylic acid cycle enzyme complex“ and B shows the corrected
ontology structure in the current GO cellular component ontology hierarchy.
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[17]. For example, the TRAMP complex is found only
in the nucleus, while the exosome complex is found in
both the cytoplasm and the nucleus yet in GO both
complexes had the same part_of relation to nucleus,
with the exosome complex having a further part_of rela-
tion to cytoplasm. To remedy this situation, the scope
of the part_of relationship was limited to specifically
refer to the all-some relationship, and the graph altered
accordingly. Further, new relationship types have been
introduced [18] to address other consistency issues with
the use of part_of in GO:
￿ Regulation Relationships
Before the introduction of the regulation relationships, all
regulatory processes in GO were made part_of the pro-
cesses they regulated, which was insufficient to capture
the biology because not all regulatory processes are inte-
gral to the processes they regulate. For example, a kinase
which phosphorylates a transcription factor and thus reg-
ulates its translocation from the cytoplasm to the nucleus
regulates transcription. However, the kinase is not part of
the transcription machinery and thus does not itself play
a direct role in the process of transcription.
￿ Has_part relationship
The use of the part_of relationship in the spliceosomal
component terms led to a logical flaw, sometimes referred
to as a true path violation, in the ontology. The term “U5
snRNP” was a part_of descendant of both the term “major
(U2-dependent) spliceosome” and the term “minor (U12-
dependent) spliceosome”. Most eukaryotic organisms have
two forms of spliceosomes, each of which contains five
snRNP complexes, four which are unique to that type, and
one which is found in both types of spliceosomes. While it
is true biologically that both the major (U2) and the minor
(U12) forms of the spliceosome contain the U5 snRNP,
any specific U5 snRNP complex is not present in both
forms of the spliceosome at the same time. Further, some
organisms, e.g. S. cerevisiae, do not have the minor spli-
ceosome. The “U5 snRNP” part_of the “minor (U12-
dependent) spliceosome” relationship leads to the conclu-
sion that the S. cerevisiae genes annotated to the term “U5
snRNP” are present in the minor spliceosome, which is
not true. During a major revision of the spliceosomal com-
plex terms, new terms were added to represent the differ-
ent spliceosomal complexes that are recognized during
various stages of the spliceosomal assembly/disassembly
cycle. The has_part relationship was then used to capture
the biological relationships between some of the large spli-
ceosomal complexes and the smaller snRNP complexes,
thus more accurately describing relationships between
complexes and subcomplexes in the cellular component
ontology (and similarly in the biological process ontology)
that were either misrepresented or not represented
previously.
Discussion
Like other ontologies in OBO, GO can be used as a plat-
form for data sharing only insofar as it accurately captures
current biological knowledge. GO terms are expected to
refer to real biological entities and processes, and thus the
definitions and relations used to characterise these terms
need to reflect established knowledge about those entities
and processes. OBO view this as a crucial principle under-
lying the development and use of ontologies in biology,
and yet its application in practice is not straightforward.
As illustrated by the cases discussed above, ontology shifts
tend to happen for a variety of different reasons and to
affect the ontology to varying degrees. Some shifts, such as
the introduction of regulation and has_part relationships
in GO (ontology shift 5), have a deep impact on the whole
structure of the ontology; other shifts, such as the change
in the GO terms related to serotonin secretion (ontology
shift 1), have a more limited impact, affecting only a speci-
fic part of the ontology. Interestingly, in cases such as the
term ‘immune response’ (ontology shift 3), a small shift in
a definition or the choice of a term affects several of the
related terms within the ontology. In all of these cases, the
expert judgement and manual intervention by curators
appears key to the appropriate development of an ontol-
ogy. This is because carrying out these ontology shifts
involves a complex set of skills. To effect the shifts illu-
strated above, curators are required to find and interpret
new information coming from biological research to work
out whether, and how, that affects the existing structure
and content of GO; and to assess the representation of
biological reality given within the GO, so as to judge how,
if at all, it needs to be changed to accommodate new infor-
mation. This means that in order to update GO, its cura-
tors need to be able to adequately understand and
represent research carried out in contemporary experi-
mental biology. As in the example of the cytoskeleton
(ontology shift 4), they need to be able to spot discoveries
relevant to how ontology terms are structured and defined,
and work out how an ontology needs to change in
response to new knowledge. On the one hand, this
requires appropriate training in information technology
and computer science, so as to be able to design, develop
and modify ontologies. On the other hand, curators also
need to be familiar with the scientific knowledge that their
ontology aims to capture, the methods through which
such knowledge is obtained, and the importance attached
to specific discoveries and evidence by the relevant
research communities.
Conclusion
The difficult judgments and decision-making processes
involved in keeping an ontology up to date explain the
relatively slow pace in implementing even well-circum-
scribed changes. This situation will certainly improve as
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lised and automated. The OBO Foundry, for instance, is
seeking to identify standard solutions that will hopefully
enable the automation of at least some curatorial tasks [6].
Nevertheless, the examples above point to the difficulties
involved in applying general standards to the development
of a specific ontology. Ontology curation aims to produce
a faithful representation of knowledge domains as they
keep developing, which requires the translation of general
guidelines into specific representations of reality and an
understanding of how scientific knowledge is produced
and constantly updated. In this context, it is important
that trained curators with technical expertise in the scien-
tific field(s) in question are involved in supervising ontol-
ogy shifts and identifying inaccuracies.
Methods
This is a qualitative study based on an in-depth analysis
of specific examples of ontology shifts, each of which is
discussed by the curator responsible for implementing it.
The curators involved in this study were recruited by
Sabina Leonelli via an email request for collaboration on
exploring ontology shifts in GO, to which they freely
responded by contributing what they saw as particularly
interesting examples from their work. The selection of
the examples used here is thus dependent on the specific
expertise and interests of the authors of this paper, as
usual in qualitative studies of this kind. The examples of
ontology shifts are grouped into five categories, depend-
ing on the scientific circumstances that warranted them:
(1) the emergence of anomalies; (2) the extension of the
scope of GO; (3) divergence in how terminology is used
across user communities; (4) new discoveries that change
the meaning of the terms used and their relations to each
other; and (5) the extension of the range of relations used
to link entities or processes described by GO terms.
Curators selected these specific cases on the basis of
what they perceived as their typicality (how well they
exemplify other cases within the same category); their
intelligibility (the ease with which they could be
explained within the word limits of this review); and their
significance (the extent to which they impacted the struc-
ture and content of GO). A quantitative study would be
needed to determine the frequency with which each type
of ontology shift has appeared in GO (or any other bio-
ontology). Due to the current lack of such quantitative
data, there is no relation between the order in which the
ontology shifts are listed in this paper and the frequency
with which they occur in practice.
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